InvestLog
Back to Market返回行情

KARD Kardigan, Inc.

NASDAQHealthcare
$21.02-4.41%ClosedMarket Cap: $1.88B

As of 2026-07-16

Why KARD matters now

Kardigan, Inc. (KARD) is a US stock in Healthcare. The latest InvestLog snapshot shows $21.02 with -4.41% on the session and $1.88B in market capitalization.

The latest indexable market news headline is "Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares" from Business Wire.

Latest News

Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional SharesBusiness Wire · 2026-06-22
Kardigan rises in Nasdaq debut after upsized $400 million IPOReuters · 2026-06-18
Kardigan Announces Pricing of Upsized Initial Public OfferingBusiness Wire · 2026-06-17
Heart drug developer Kardigan targets $1.4 billion valuation in US IPOReuters · 2026-06-11
Kardigan Begins Process For IPO On Cardiovascular Treatments PromiseSeeking Alpha · 2026-06-02

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

NASDAQ

Beta

0.00

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.